January 6, 2023
Via: The Wall Street JournalChinese drugmaker CanSino Biologics Inc. started trial production of a vaccine targeting new variants of Covid-19 that are behind the country’s current outbreak, which would be among the first developed in China using the mRNA technology that drove inoculation in […]
November 3, 2022
Via: The Wall Street JournalModerna Inc.’s third-quarter revenue fell by nearly a third and the pharmaceutical company cut its outlook, saying as part of its earnings report that supply constraints for its Covid-19 vaccines might sap as much as $3 billion in sales this […]
July 9, 2024
June 25, 2024